1-8 of 8
Rami Komrokji
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and efficacy of luspatercept for the treatment of anemia in patients with myelofibrosis

Clinical Trials & Observations
Aaron T. Gerds, Claire Harrison, Jean-Jacques Kiladjian, Ruben Mesa, Alessandro M. Vannucchi, Rami Komrokji, Prithviraj Bose, Marina Kremyanskaya, Adam J. Mead, Jason Gotlib, Shelonitda Rose, Fabian Sanabria, Niloufar Marsousi, Ana Carolina Giuseppi, Huijing Jiang, Jeanne M. Palmer, Kelly McCaul, Vincent Ribrag, Francesco Passamonti
Journal: Blood Advances
Blood Adv (2024) 8 (17): 4511–4522.
https://doi.org/10.1182/bloodadvances.2024012939
Published: 2024
Includes: Supplemental data
Journal Articles

Mutations highly specific for secondary AML are associated with poor outcomes in ELN favorable risk NPM1 -mutated AML

Onyee Chan, Najla Al Ali, Hammad Tashkandi, Austin Ellis, Somedeb Ball, Justin Grenet, Caroline Hana, Yehuda Deutsch, Ling Zhang, Mohammad Hussaini, Jinming Song, Seongseok Yun, Chetasi Talati, Andrew Kuykendall, Eric Padron, Alison Walker, Gail Roboz, Pinkal Desai, David Sallman, Kendra Sweet, Rami Komrokji, Jeffrey Lancet
Journal: Blood Advances
Blood Adv (2024) 8 (5): 1075–1083.
https://doi.org/10.1182/bloodadvances.2023011173
Published: 2024
Journal Articles

Health-related quality of life and vulnerability among people with myelodysplastic syndromes: a US national study

Clinical Trials & Observations
Gregory A. Abel, Donnie Hebert, Cecilia Lee, Dana Rollison, Nancy Gillis, Rami Komrokji, James M. Foran, Jane Jijun Liu, Tareq Al Baghdadi, Joachim Deeg, Steven Gore, Wael Saber, Steffanie Wilson, Michael Otterstatter, Jason Thompson, Christine Borchert, Eric Padron, Amy DeZern, David Cella, Mikkael A. Sekeres
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3506–3515.
https://doi.org/10.1182/bloodadvances.2022009000
Published: 2023
Includes: Supplemental data
Journal Articles

Black African-American patients with primary myelofibrosis: a comparative analysis of phenotype and survival

Naseema Gangat, Andrew Kuykendall, Najla Al Ali, Swati Goel, Maymona Abdelmagid, Aref Al-Kali, Hassan B. Alkhateeb, Kebede H. Begna, Abhishek Mangaonkar, Mark R. Litzow, William Hogan, Mithun Shah, Mrinal M. Patnaik, Animesh Pardanani, Rami Komrokji, Ayalew Tefferi
Journal: Blood Advances
Blood Adv (2023) 7 (12): 2694–2698.
https://doi.org/10.1182/bloodadvances.2022009611
Published: 2023
Journal Articles

U2AF1 and EZH2 mutations are associated with nonimmune hemolytic anemia in myelodysplastic syndromes

Rami Komrokji, Luis E. Aguirre, Najla Al Ali, Mohamad Hussaini, David Sallman, Dana Rollison, Eric Padron
Journal: Blood Advances
Blood Adv (2023) 7 (1): 1–8.
https://doi.org/10.1182/bloodadvances.2022007504
Published: 2023
Journal Articles

A prognostic model to predict survival after 6 months of ruxolitinib in patients with myelofibrosis

Clinical Trials & Observations
Margherita Maffioli, Barbara Mora, Somedeb Ball, Alessandra Iurlo, Elena Maria Elli, Maria Chiara Finazzi, Nicola Polverelli, Elisa Rumi, Marianna Caramella, Maria Cristina Carraro, Mariella D’Adda, Alfredo Molteni, Cinzia Sissa, Francesca Lunghi, Alessandro Vismara, Marta Ubezio, Anna Guidetti, Sabrina Caberlon, Michela Anghilieri, Rami Komrokji, Daniele Cattaneo, Matteo Giovanni Della Porta, Toni Giorgino, Lorenza Bertù, Marco Brociner, Andrew Kuykendall, Francesco Passamonti
Journal: Blood Advances
Blood Adv (2022) 6 (6): 1855–1864.
https://doi.org/10.1182/bloodadvances.2021006889
Published: 2022
Includes: Supplemental data
Journal Articles

SF3B1 -mutant CMML defines a predominantly dysplastic CMML subtype with a superior acute leukemia–free survival

Clinical Trials & Observations
Kitsada Wudhikarn, Sanam Loghavi, Abhishek A. Mangaonkar, Aref Al-Kali, Moritz Binder, Ryan Carr, Kaaren Reichard, Christy Finke, Matthew Howard, Naseema Gangat, Ayalew Tefferi, Rami Komrokji, Najla Ali, Terra Lasho, Rhett Ketterling, Eric Padron, Mrinal M. Patnaik
Journal: Blood Advances
Blood Adv (2020) 4 (22): 5716–5721.
https://doi.org/10.1182/bloodadvances.2020003345
Published: 2020
Includes: Supplemental data
Journal Articles

Survival following allogeneic transplant in patients with myelofibrosis

Clinical Trials & Observations
Krisstina Gowin, Karen Ballen, Kwang Woo Ahn, Zhen-Huan Hu, Haris Ali, Murat O. Arcasoy, Rebecca Devlin, Maria Coakley, Aaron T. Gerds, Michael Green, Vikas Gupta, Gabriela Hobbs, Tania Jain, Malathi Kandarpa, Rami Komrokji, Andrew T. Kuykendall, Kierstin Luber, Lucia Masarova, Laura C. Michaelis, Sarah Patches, Ashley C. Pariser, Raajit Rampal, Brady Stein, Moshe Talpaz, Srdan Verstovsek, Martha Wadleigh, Vaibhav Agrawal, Mahmoud Aljurf, Miguel Angel Diaz, Belinda R. Avalos, Ulrike Bacher, Asad Bashey, Amer M. Beitinjaneh, Jan Cerny, Saurabh Chhabra, Edward Copelan, Corey S. Cutler, Zachariah DeFilipp, Shahinaz M. Gadalla, Siddhartha Ganguly, Michael R. Grunwald, Shahrukh K. Hashmi, Mohamed A. Kharfan-Dabaja, Tamila Kindwall-Keller, Nicolaus Kröger, Hillard M. Lazarus, Jane L. Liesveld, Mark R. Litzow, David I. Marks, Sunita Nathan, Taiga Nishihori, Richard F. Olsson, Attaphol Pawarode, Jacob M. Rowe, Bipin N. Savani, Mary Lynn Savoie, Sachiko Seo, Melhem Solh, Roni Tamari, Leo F. Verdonck, Jean A. Yared, Edwin Alyea, Uday Popat, Ronald Sobecks, Bart L. Scott, Ryotaro Nakamura, Ruben Mesa, Wael Saber
Journal: Blood Advances
Blood Adv (2020) 4 (9): 1965–1973.
https://doi.org/10.1182/bloodadvances.2019001084
Published: 2020
Includes: Supplemental data